Physician

Bruno S Fang, MD

According to 2025 Medicare claims, Bruno Fang, MD (NPI: 1982692851) practices medical oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is TITAN HEALTH PARTNERS LLC (NPI: 1790396281; TIN: 852303328) and primary practice location at 08816-3340. Fang is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Fang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 716 traditional Medicare patients, billed 123,812 HCPCS/CPT codes, and received $2,267,462 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,624 prescription claims across 222 beneficiaries totaling $5,297,346 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 92 claims. Open Payments data shows 242 records totaling $2,010,428. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,905,871 and ending at $2,267,462. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,388,616 to $5,297,346. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,863 to $5,196.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	870	145,792	$1,905,871
2016	950	172,015	$2,575,578
2017	949	136,189	$2,080,183
2018	865	135,862	$2,309,834
2019	821	163,072	$2,400,071
2020	726	136,189	$2,349,424
2021	598	106,334	$1,836,750
2022	625	89,234	$1,334,069
2023	662	95,250	$1,700,329
2024	716	123,812	$2,267,462

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	222	1,318	$1,388,616
2016	239	1,383	$1,564,860
2017	274	1,644	$2,776,534
2018	250	1,546	$2,894,154
2019	249	1,667	$3,734,739
2020	218	1,578	$3,647,117
2021	199	1,520	$4,193,934
2022	207	1,467	$4,058,719
2023	221	1,765	$4,553,807
2024	222	1,624	$5,297,346

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	245	$66,284
2016	73	453	$59,405
2017	40	457	$53,506
2018	72	517	$35,831
2019	N/R	367	$26,586
2020	N/R	300	$20,473
2021	N/R	195	$7,680
2022	N/R	132	$5,187
2023	N/R	81	$2,491
2024	N/R	92	$5,205

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	249	622	$113
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	274	416	$81
96372	Injection of drug or substance under skin or into muscle	132	438	$13
36415	Insertion of needle into vein for collection of blood sample	278	698	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	134	550	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	16	480	$318,315
Aranesp	Darbepoetin Alfa In Polysorbat	104	2,590	$272,762
Revlimid	Lenalidomide	18	504	$270,721
Somatuline Depot	Lanreotide Acetate	27	774	$247,915
Bosulif	Bosutinib	12	360	$236,075

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	17	$3,382
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	25	$909
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	25	$480
J9190	Injection, fluorouracil, 500 mg	N	N/R	25	$435

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$361	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	220	$2,010,066	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Bruno S. Fang, MD?

Tedicare shows public-source Medicare data for Bruno S. Fang, MD (NPI 1982692851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruno S. Fang, MD have ACO affiliation data?

Bruno S. Fang, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Bruno S. Fang, MD?

Bruno S. Fang, MD is linked to TITAN HEALTH PARTNERS LLC (billing NPI 1790396281) in the available physician profile data.

Does Bruno S. Fang, MD have Open Payments data?

Bruno S. Fang, MD has 242 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.